Survival and Prognostic Factors of Ultra-Central Tumors Treated with Stereotactic Body Radiotherapy.
Viola SalvestriniMarloes DuijmMauro LoiJoost J NuyttensPublished in: Cancers (2022)
risk-adaptive SBRT for ultra-central tumors is safe and effective, even if it remains a high-risk clinical scenario.